(Q44159298)

English

Decreased platelet reactivity in blood anticoagulated with bivalirudin or enoxaparin compared with unfractionated heparin: implications for coronary intervention

scientific article published in June 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Decreased platelet reactivity in blood anticoagulated with bivalirudin or enoxaparin compared with unfractionated heparin: implications for coronary intervention (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1 reference

based on heuristic

inferred from title

author name string

Atul Aggarwal

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Burton E Sobel

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

David J Schneider

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

publication date

1 June 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Journal of Thrombosis and Thrombolysis

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

161-165

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Inhibition of Thrombin Induced Aggregation of Human Platelets by Heparin

1 reference

https://pubmed.ncbi.nlm.nih.gov/12355033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelet reactivity in coronary ostial blood: a reflection of the thrombotic state accompanying plaque rupture and of the adequacy of anti-thrombotic therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12355033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The lack of augmentation by aspirin of inhibition of platelet reactivity by ticlopidine

1 reference

https://pubmed.ncbi.nlm.nih.gov/12355033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of Heparin and Heparin Fractions on Platelet Aggregation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12355033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/12355033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blood clotting in minimally altered whole blood

1 reference

https://pubmed.ncbi.nlm.nih.gov/12355033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential effects of anticoagulants on the activation of platelets ex vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/12355033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased platelet reactivity in patients given orbofiban after an acute coronary syndrome: an OPUS-TIMI 16 substudy. Orbofiban in Patients with Unstable coronary syndromes. Thrombolysis In Myocardial Infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/12355033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/12355033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The potentiation of platelet aggregation and adhesion by heparin in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/12355033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelet reactivity characterized prospectively: a determinant of outcome 90 days after percutaneous coronary intervention

1 reference

https://pubmed.ncbi.nlm.nih.gov/12355033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimally functional fluorescein isothiocyanate-labelled fibrinogen for quantitative studies of binding to activated platelets and platelet aggregation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12355033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/12355033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differences between activation thresholds for platelet P-selectin glycoprotein IIb-IIIa expression and their clinical implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/12355033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty

1 reference

https://pubmed.ncbi.nlm.nih.gov/12355033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time and dose dependent augmentation of inhibitory effects of abciximab by aspirin

1 reference

https://pubmed.ncbi.nlm.nih.gov/12355033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variable responses to inhibition of fibrinogen binding induced by tirofiban and eptifibatide in blood from healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/12355033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biphasic effects of hemodialysis on platelet reactivity in patients with end-stage renal disease: a potential contributor to cardiovascular risk

1 reference

https://pubmed.ncbi.nlm.nih.gov/12355033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin neutralization by platelet-rich thrombi. Role of platelet factor 4

1 reference

https://pubmed.ncbi.nlm.nih.gov/12355033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1020478923794

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44159298&oldid=2206470099"